News | Mammography | November 09, 2016

Study finds recall rates cut in half when mammograms compared to two or more prior examinations, compared to those interpreted without prior comparisons

mammography, comparison, prior examinations, UCSF study, American Journal of Roentgenology

November 9, 2016 — The recall rate of screening mammography is reduced when radiologists compare with more than one prior mammogram, a study published in the October 2016 issue of the American Journal of Roentgenology said.

"Our findings suggest that radiologists who make comparisons with more than one prior examination at screening mammography will have more true-positive outcomes and fewer false-positive outcomes," said study co-author Kimberly M. Ray, a radiologist with the Department of Radiology and Biomedical Imagining, University of California, San Francisco (UCSF). Ray is among several authors who published the paper, "Improving Screening Mammography Outcomes Through Comparison With Multiple Prior Mammograms."

"We have shown that the recall rate (percentage of cases with a potential abnormality that require additional imaging evaluation) for screening mammography decreases, whereas the positive predictive value of recall (PPV1) and the cancer detection rate increase when two or more prior examinations are used for comparison relative to comparison with a single prior examination," Ray said.

A large body of evidence indicates that screening mammography reduces the breast cancer mortality rate among women 40 years and older by approximately 20-40 percent. However, false-positives are frequently cited as the downside to mammographic screening because they cause patient anxiety, additional radiation exposure, biopsies and increased healthcare costs. The U.S. Preventive Services Task Force cited excessive false-positive results as a reason to avoid routine screening of women in their 40s and to recommend less frequent screening among older women.

"Consequently, although the reduced mortality rate associated with screening mammography arguably far outweighs the potential harms of the examination, a reduction in false-positive results should be a priority to ensure that support for and access to screening mammography are maintained," Ray said. "Because millions of women undergo screening mammography each year in the United States, even a small reduction in the recall rate may result in a widespread benefit."

Study authors retrospectively analyzed 46,288 consecutive screening mammograms performed at UCSF for 22,792 women. The examinations were divided into three groups: those interpreted without comparison with prior mammograms, those interpreted in comparison with one prior examination, and those interpreted in comparison with two or more prior examinations.

The recall rate for mammograms interpreted without comparison to prior examinations was 16.6 percent, whereas that for mammograms compared to one prior examination was 7.8 percent, and that for mammograms compared to two or more prior examinations was 6.3 percent.

For more information: www.ajronline.org


Related Content

News | PET Imaging

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...

Time May 30, 2025
arrow
News | Imaging Software Development

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently ...

Time May 28, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
Subscribe Now